Nachrichten und Videos - ACCURAY INC.

Accuray to Participate at 37th Annual Roth Conference PR Newswire MADISON, Wis., March 12, 2025 MADISON, Wis. , March 12, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the 37 th Annual Roth Conference taking place on March 16 -18, 2025 in Dana Point, California . Management will participate in a fireside chat on Tuesday, March 18, 2025 , at 9:30am PT / 12:30pm ET , and will be available for one-on-one meetings with investors. A live webcast of the...

Accuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance PR Newswire MADISON, Wis., Feb. 5, 2025 MADISON, Wis. , Feb. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2024 . Key Fiscal Q2 Highlights: Strong second quarter and first half results; raising fiscal year 2025 guidance Total net revenue was $116.2 million , an increase of 8 percent year-over-year Net income was $2.5...

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product PR Newswire MADISON, Wis., Jan. 23, 2025 MADISON, Wis. , Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo ® C Radiation Treatment Delivery System, a product built in...

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product PR Newswire MADISON, Wis., Jan. 23, 2025 MADISON, Wis. , Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo ® C Radiation Treatment Delivery System, a product built in...

Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025 PR Newswire MADISON, Wis., Jan. 22, 2025 MADISON, Wis. , Jan. 22, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2025, ended December 31, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on February 5, 2025 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747...

Leonel Peralta to Join Accuray as Chief Operations Officer PR Newswire MADISON, Wis., Jan. 21, 2025 MADISON, Wis. , Jan. 21, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Leonel Peralta is joining the company as Senior Vice President, Chief Operations Officer, effective February 3, 2025 . Mr. Peralta will be responsible for leading worldwide manufacturing operations including driving alignment of operations with corporate business goals, maximizing supply chain...

Accuray Announces China National Medical Products Administration Approval of the Radixact® SynC™ and CyberKnife® S7™ Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo® C System PR Newswire MADISON, Wis., Jan. 13, 2025 MADISON, Wis. , Jan. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company's Radixact SynC™ System and CyberKnife ® S7™ System have been approved by the Chinese National Medical Products...

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules PR Newswire MADISON, Wis., Nov. 26, 2024 MADISON, Wis. , Nov. 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy , the company's new Vice President, Corporate Controller. As a material inducement to Mr. Murphy joining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee approved...

Accuray Reports Fiscal 2025 First Quarter Financial Results PR Newswire MADISON, Wis., Nov. 6, 2024 Strong Start to Fiscal Year, Raises 2025 Guidance MADISON, Wis. , Nov. 6, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2024 . "We continue to make solid progress in the execution of our strategic growth agenda and performed better than expected in the first quarter and are on track to deliver our fiscal 2025...

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024 PR Newswire MADISON, Wis., Oct. 23, 2024 MADISON, Wis. , Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on November 6, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747...

Accuray Appoints Michael Murphy as VP, Corporate Controller PR Newswire MADISON, Wis., Oct. 21, 2024 MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy , CPA has joined the company as Vice President, Corporate Controller. Mr. Murphy will be responsible for leading the global accounting function including corporate tax, regulatory reporting, accounting policies, and risk management, along with associated budgetary and...

New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer PR Newswire MADISON, Wis., Oct. 17, 2024 The Precision of Stereotactic Body Radiation Therapy (SBRT), an Advanced Treatment Technique, Enables Treatment in Five Days, Significantly Reducing the Time Men Must Spend Undergoing Care MADISON, Wis. , Oct. 17, 2024...

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence PR Newswire MADISON, Wis., Oct. 15, 2024 MADISON, Wis. , Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke , who has served as interim CEO during Ms. Winter's absence, will continue in his position as...

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training PR Newswire MADISON, Wis., Sept. 30, 2024 Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care New Accuray CyberComm™ tool was used to significantly reduce the CyberKnife ® S7™ System's...

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution PR Newswire MADISON, Wis., Sept. 10, 2024 The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments MADISON, Wis. , Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is...

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence PR Newswire MADISON, Wis., Sept. 3, 2024 MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately. Accuray Senior Vice President and Chief Commercial Officer Sandeep Chalke...

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™ PR Newswire MADISON, Wis., Aug. 27, 2024 Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced...

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results PR Newswire MADISON, Wis., Aug. 14, 2024 14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wis. , Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2024, ended June 30, 2024 . Fourth Quarter Fiscal 2024 Summary Net revenue of $134.3 million , an increase of 13.5 percent from the same period in the prior fiscal year. Net...

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology PR Newswire MADISON, Wis. and DAYTONA BEACH, Fla., Aug. 13, 2024 New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments MADISON, Wis. and DAYTONA BEACH, Fla. , Aug. 13, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and...

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024 PR Newswire MADISON, Wis., July 31, 2024 MADISON, Wis. , July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on August 14, 2024 . The conference call dial-in numbers are (833) 316-0563 ( USA ) or (412) 317-5747...